| 48691 | 48691 | Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine | Active, not recruiting | No Results Available | Myelodysplastic Syndromes|Refractory Anemia With Excess Blasts|Chronic Myelomonocytic Leukemia|Cytopenia | Drug: rigosertib sodium | https://ClinicalTrials.gov/show/NCT01928537 |
| 48692 | 48692 | Chemotherapy for Patients With Cancer of the Stomach | Recruiting | No Results Available | First-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus or | Drug: DOS2W|Drug: DOS3W | https://ClinicalTrials.gov/show/NCT01928524 |
| 48693 | 48693 | Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy | Recruiting | No Results Available | Chronic Hepatitis B | Drug: peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly|Drug: Nucleos(t)ide analogue therapy | https://ClinicalTrials.gov/show/NCT01928511 |
| 48694 | 48694 | Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis | Not yet recruiting | No Results Available | Arteriovenous Fistulae|Arteriovenous Graft | Device: Paclitaxel Eluting Balloon Angioplasty|Device: Percutaneous Transluminal Angioplasty (PTA) | https://ClinicalTrials.gov/show/NCT01928498 |
| 48695 | 48695 | Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer | Recruiting | No Results Available | Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer | Other: active surveillance|Drug: Sunphenon|Other: laboratory biomarker analysis|Other: Questionnaire Administration | https://ClinicalTrials.gov/show/NCT01928485 |
| 48696 | 48696 | Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years | Completed | Has Results | H7N9 Influenza | Biological: H7N9c low dose with adjuvant|Biological: H7N9c medium dose with adjuvant|Biological: H7N9c high dose with adjuvant|Biological: H7N9c high dose without adjuvant | https://ClinicalTrials.gov/show/NCT01928472 |
| 48697 | 48697 | Phase 1b Trial of BGJ398/BYL719 in Solid Tumors | Recruiting | No Results Available | Advanced Solid Tumors,|Metastatic Solid Tumors | Drug: BGJ398|Drug: BYL719 | https://ClinicalTrials.gov/show/NCT01928459 |
| 48698 | 48698 | Lithium for Suicidal Behavior in Mood Disorders | Recruiting | No Results Available | Depressive Disorder|Bipolar Disorder|Suicide|Suicide, Attempted | Drug: Lithium|Drug: Placebo | https://ClinicalTrials.gov/show/NCT01928446 |
| 48699 | 48699 | Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis | Active, not recruiting | No Results Available | Urinary Tract Infections|Acute Pyelonephritis | Drug: Finafloxacin 800 mg i.v. once daily|Drug: Finafloxacin placebo i.v. once daily|Drug: Finafloxacin 800 mg tablets (as four 200 mg tablets) once daily|Drug: Finafloxacin placebo tablets (as four tablets) once daily|Drug: Ciprofloxacin 400 mg i.v. two times daily|Drug: Ciprofloxacin placebo i.v. two times daily|Drug: Ciprofloxacin 500 mg oral (as two 250 mg capsules) two times daily|Drug: Ciprofloxacin placebo oral (as two capsules each) two times daily | https://ClinicalTrials.gov/show/NCT01928433 |
| 48700 | 48700 | A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease | Recruiting | No Results Available | Alzheimer's Disease|Dementia | Drug: Drug: NIC5-15|Drug: Placebo | https://ClinicalTrials.gov/show/NCT01928420 |
| 48701 | 48701 | Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts | Recruiting | No Results Available | HIV-1 Infection|Immunosuppression-related Infectious Disease | Drug: DARUNAVIR|Drug: ATAZANAVIR | https://ClinicalTrials.gov/show/NCT01928407 |
| 48702 | 48702 | A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab in Subjects With Advanced or Metastatic Solid Tumors | Recruiting | No Results Available | Advanced or Metastatic Solid Tumors | Biological: Nivolumab|Biological: Ipilimumab | https://ClinicalTrials.gov/show/NCT01928394 |
| 48703 | 48703 | Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability | Completed | No Results Available | Diabetic Neuropathy, Painful; Diabetic Neuropathies | Drug: AZD5213 + pregabalin|Drug: Placebo|Drug: pregabalin capsules | https://ClinicalTrials.gov/show/NCT01928381 |
| 48704 | 48704 | A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma. | Recruiting | No Results Available | Asthma | Drug: AMG 282|Drug: AMG 282 Matching Placebo | https://ClinicalTrials.gov/show/NCT01928368 |
| 48705 | 48705 | Cognitive Dysfunction in People Who Are Obese But Metabolically Healthy | Not yet recruiting | No Results Available | Metabolic Syndrome | | https://ClinicalTrials.gov/show/NCT01928355 |
| 48706 | 48706 | The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia | Recruiting | No Results Available | Hyperlipoproteinemia | Drug: Coenzyme A|Drug: Placebo | https://ClinicalTrials.gov/show/NCT01928342 |
| 48707 | 48707 | A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes | Recruiting | No Results Available | Type I Diabetes | Drug: Exenatide (Bydureon®)|Drug: Placebo | https://ClinicalTrials.gov/show/NCT01928329 |
| 48708 | 48708 | A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers | Completed | No Results Available | Healthy | Drug: Mizolastine domestic (made in China)|Drug: Mizolastine (imported) | https://ClinicalTrials.gov/show/NCT01928316 |
| 48709 | 48709 | Predicting Oxycodone Dose From Oral Fluid Drug Levels | Completed | No Results Available | Chronic Pain | | https://ClinicalTrials.gov/show/NCT01928303 |
| 48710 | 48710 | Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer | Recruiting | No Results Available | Stomach Neoplasms|Esophageal Neoplasms | Drug: Irinotecan|Drug: Trastuzumab|Drug: Oxaliplatin|Drug: Leucovorin|Drug: Fluorouracil | https://ClinicalTrials.gov/show/NCT01928290 |
| 48711 | 48711 | Weaning From Mechanical Ventilation: Spontaneous Breathing Trial and the Assessment of Work of Breathing | Completed | No Results Available | Weaning Failure | | https://ClinicalTrials.gov/show/NCT01928277 |
| 48712 | 48712 | Physical Activity in Insurance Medicine: Effects on Patients With Psychiatric Disorders | Recruiting | No Results Available | Depressive Disorder|Somatoform Disorder|Anxiety Disorder|Personality Disorder | Behavioral: Physical activity | https://ClinicalTrials.gov/show/NCT01928264 |
| 48713 | 48713 | Promoting Smoking Cessation in the Community Via Quit to Win Contest 2013 | Completed | No Results Available | Smoking Cessation | Behavioral: Informed early monetary incentive|Behavioral: Uninformed early monetary incentive | https://ClinicalTrials.gov/show/NCT01928251 |
| 48714 | 48714 | Physiologic Effects of Noninvasive Neurally Adjusted Ventilatory Assist (NAVA) Versus Noninvasive Pressure Support Ventilation in Patients at Risk for Respiratory Distress Needed Preventive Used of Noninvasive Ventilation After Extubation. | Completed | No Results Available | Acute Respiratory Distress | Device: Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).|Device: Noninvasive pressure support ventilation (NPSV) | https://ClinicalTrials.gov/show/NCT01928238 |
| 48715 | 48715 | Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL | Enrolling by invitation | No Results Available | Cervical High Grade Squamous Intraepithelial Lesion | Biological: Human Papillomavirus vaccine | https://ClinicalTrials.gov/show/NCT01928225 |
| 48716 | 48716 | Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysis | Completed | No Results Available | Parkinson Disease | Device: Optical coherence tomography | https://ClinicalTrials.gov/show/NCT01928212 |
| 48717 | 48717 | Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant | Recruiting | No Results Available | Posttransplant Diabetes Mellitus | Drug: Sitagliptin|Drug: Placebo | https://ClinicalTrials.gov/show/NCT01928199 |
| 48718 | 48718 | FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer | Recruiting | No Results Available | Estrogen Receptor Positive|HER2/Neu Negative|Male Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer | Drug: Fluorothymidine F-18|Procedure: Positron Emission Tomography|Other: Laboratory Biomarker Analysis | https://ClinicalTrials.gov/show/NCT01928186 |
| 48719 | 48719 | Self-Help Video for Insomnia in College Students | Suspended | No Results Available | Sleep Initiation and Maintenance Disorders | Behavioral: Abbreviated cognitive behavioral therapy|Behavioral: Sleep education/sleep hygiene | https://ClinicalTrials.gov/show/NCT01928173 |
| 48720 | 48720 | Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib | Withdrawn | No Results Available | Recurrent Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer | Drug: pemetrexed disodium|Drug: carboplatin|Drug: cisplatin|Drug: erlotinib hydrochloride|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT01928160 |